||Optional Breakfast Sessions - Choose from 3
(You must register and pay separately for breakfast sessions during the registration process.)
Breakfast M: Non-Medical Management of IBS and IBD
Moderator: Edith Y. Ho, MD, MS, FACG
- Behavioral Therapy in IBS and IBD
Megan E. Riehl, PsyD
Discuss behavioral therapy in the management of IBS and IBD.
- Dietary Management in IBS and IBD
Edith Y. Ho, MD, MS, FACG, and Gabriela Gardner, RDN-AP, LD, CNSC
Describe the evidence surrounding different dietary approaches to managing IBS and IBD.
- Other CAM: Plants, Needles, Electricity, and More
Linda Anh B. Nguyen, MD
Outline the approach to implementing complementary and alternative medicine into clinical practice.
Breakfast N: Non-IBD Colitides
Moderator: Lisa L. Strate, MD, MPH, FACG
- Checkpoint Inhibitor Colitis
Shilpa Grover, MD
Describe the clinical presentation, diagnosis, and management
- SUDD and SCAD
Lisa L. Strate, MD, MPH, FACG
Analyze the data in support of symptomatic uncomplicated diverticular disease (SUDD) and segmental colitis associated with diverticulosis (SCAD) as distinct clinical entities, and review the management options.
- Ischemia and Microscopic Colitis
Neil H. Stollman, MD, FACG
Discuss Ischemia and Microscopic Colitis and how to recognize, diagnose, and treat them.
Breakfast O: Eosinophilic Esophagitis: Key Updates and Optimal Management
Moderator: Nicholas J. Shaheen, MD, MPH, FACG
- Eosinophilic Esophagitis in Children and Adolescents: Implications for the Future
Calies D. Menard-Katcher, MD
Describe the epidemiology and clinical presentation of pediatric EoE, and discuss the transition of patients from pediatric to adult care, and the implications for adult care.
- Diagnosing Eosinophilic Esophagitis: Current Guidelines and Key Developments
Nicholas J. Shaheen, MD, MPH, FACG
Evaluate new guidelines for EoE and how they will impact PPI utilization, and discuss the new technologies and how they will affect diagnostic algorithms.
- Selecting the Ideal Treatment Option for Your Patient With Eosinophilic Esophagitis
Kristle L. Lynch, MD
Discuss the current standard of care for EoE treatment and emerging therapies
||Simultaneous Symposia Session 5 - Choose from 2
Symposium 5A: Monitoring Therapies in IBD: So You Started Treatment, Now What Do You Do?
Moderator: Bincy P. Abraham, MD, FACG
- Treat-to-Target 2019: Is It Really the Target or the Process?
Edward V. Loftus, Jr., MD, FACG
Identify the right target for the right patient based on patient and disease-related risk factors.
- Therapeutic Drug Monitoring: Is It For Everyone?
Bincy P. Abraham, MD, FACG
Formulate strategies for serial disease activity monitoring.
- Withdrawing Medications: I Feel Great, Now When Can I Stop?
David P. Hudesman, MD
Describe clinical scenarios where de-escalation may be appropriate.
Symposium 5B: Topics in Cirrhosis and Portal Hypertension
Moderator: Ira M. Jacobson, MD. FACG
- Management of Gastroesophageal Varices
Ira M. Jacobson, MD. FACG
Discuss the management of gastroesophageal varices including prophylactic, active, and post-bleeding therapies.
- Update on the Management of Ascites and Its Complications
Arun J. Sanyal, MD
Assess the diagnosis and management of ascites and its complications, including spontaneous bacterial peritonitis and hepatorenal syndrome.
- Liver Transplant Update for the Gastroenterologist
Kimberly A. Brown, MD
Describe the current allocation system and evolving indications for liver transplant.